|
| 31990564 | Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRP. | Mol Pharm | 2020 |
| 31167838 | Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways. | Drug Metab Dispos | 2019 |
| 28230985 | Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1). | J Med Chem | 2017 |
| 26597253 | The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin. | Clin Pharmacokinet | 2016 |
| 23241029 | Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. | J Med Chem | 2013 |
| 23649425 | Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8). | J Pharm Sci | 2013 |
| 23417511 | Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice. | Pharm Res | 2013 |
| 22768295 | Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter. | PLoS One | 2012 |
| 20090676 | Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease. | Clin Pharmacol Ther | 2010 |
| 18843263 | Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite. | Clin Pharmacol Ther | 2009 |
| 19483665 | Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. | Pharmacogenet Genomics | 2009 |
| 17609685 | Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. | Clin Pharmacol Ther | 2008 |
| 17192770 | effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. | Clin Pharmacol Ther | 2007 |
| 17431031 | Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. | Drug Metab Dispos | 2007 |
| 16258024 | Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. | J Pharmacol Exp Ther | 2006 |
| 17010096 | Dissociation of food and opiate preference by a genetic mutation in zebrafish. | Genes Brain Behav | 2006 |
| 16395286 | Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. | J Cereb Blood Flow Metab | 2006 |
| 16421287 | Induction of renal cytochrome P450 arachidonic acid epoxygenase activity by dietary gamma-linolenic acid. | J Pharmacol Exp Ther | 2006 |
| 16628600 | Liquid chromatographic tandem mass spectrometric assay for the uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in human plasma. | Rapid Commun Mass Spectrom | 2006 |
| 16624870 | Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. | Drug Metab Dispos | 2006 |
| 16581945 | Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. | Drug Metab Dispos | 2006 |
| 16698890 | In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay. | Drug Metab Dispos | 2006 |
| 15778422 | Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics. | J Clin Pharmacol | 2005 |
| 14659435 | Liquid chromatographic-tandem mass spectrometric assay for the simultaneous determination of didanosine and stavudine in human plasma, bronchoalveolar lavage fluid, alveolar cells, peripheral blood mononuclear cells, seminal plasma, cerebrospinal fluid and tonsil tissue. | J Chromatogr B Analyt Technol Biomed Life Sci | 2004 |
| 15146179 | 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. | Nat Med | 2004 |
| 15286055 | Effects of uremic toxins on hepatic uptake and metabolism of erythromycin. | Drug Metab Dispos | 2004 |
| 15569390 | Pharmacokinetics of quinacrine in the treatment of prion disease. | BMC Infect Dis | 2004 |